Caxton Associates (New York)’s LivaNova LIVN Stock Holding History
Bought
Maintained
Sold
Other funds holding LIVN
O
HM
Caxton Associates (New York)'s LIVN Position: Q1 2018 in Review
Caxton Associates (New York) sold out of LivaNova (LIVN) in Q1 2018, closing a stake of 10,054 shares — an estimated $804K sold.
Caxton Associates (New York) first reported a position in LIVN in Q4 2017 and held it in 1 quarter. The position peaked at $804K in Q4 2017. 230 funds tracked by Wall St. Rank hold LIVN as of Q1 2018.
- Caxton Associates (New York) reported no remaining LivaNova position as of Q1 2018 after selling out during the quarter.
- Caxton Associates (New York) sold 10,054 LivaNova shares in Q1 2018, an estimated $804K.
- Caxton Associates (New York) first reported a position in LivaNova in Q4 2017 and held it in 1 quarter.
- Caxton Associates (New York)'s LivaNova position peaked at $804K in Q4 2017.
- 230 funds tracked by Wall St. Rank held LivaNova as of Q1 2018.
Based on Caxton Associates (New York)'s 13F filing for Q1 2018, filed 15 May 2018.